Maraganore DM - Search Results

1

Parkin variants in North American Parkinson's disease: cases and controls.

Lincoln SJ, Maraganore DM, Lesnick TG, Bounds R, de Andrade M, Bower JH, Hardy JA, Farrer MJ. Lincoln SJ, et al. Among authors: maraganore dm. Mov Disord. 2003 Nov;18(11):1306-11. doi: 10.1002/mds.10601. Mov Disord. 2003. PMID: 14639672

2

Complex relationship between Parkin mutations and Parkinson disease.

West A, Periquet M, Lincoln S, Lücking CB, Nicholl D, Bonifati V, Rawal N, Gasser T, Lohmann E, Deleuze JF, Maraganore D, Levey A, Wood N, Dürr A, Hardy J, Brice A, Farrer M; French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility on Parkinson's Disease. West A, et al. Am J Med Genet. 2002 Jul 8;114(5):584-91. doi: 10.1002/ajmg.10525. Am J Med Genet. 2002. PMID: 12116199

3

Functional association of the parkin gene promoter with idiopathic Parkinson's disease.

West AB, Maraganore D, Crook J, Lesnick T, Lockhart PJ, Wilkes KM, Kapatos G, Hardy JA, Farrer MJ. West AB, et al. Hum Mol Genet. 2002 Oct 15;11(22):2787-92. doi: 10.1093/hmg/11.22.2787. Hum Mol Genet. 2002. PMID: 12374768

4

Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease.

Maraganore DM, Farrer MJ, Hardy JA, Lincoln SJ, McDonnell SK, Rocca WA. Maraganore DM, et al. Neurology. 1999 Nov 10;53(8):1858-60. doi: 10.1212/wnl.53.8.1858. Neurology. 1999. PMID: 10563640

5

Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease.

Maraganore DM, Farrer MJ, Hardy JA, McDonnell SK, Schaid DJ, Rocca WA. Maraganore DM, et al. Mov Disord. 2000 Jul;15(4):714-9. doi: 10.1002/1531-8257(200007)15:4<714::aid-mds1018>3.0.co;2-3. Mov Disord. 2000. PMID: 10928584

6

Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease.

Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Bower JH, et al. Among authors: maraganore dm. Mov Disord. 2000 Sep;15(5):819-25. doi: 10.1002/1531-8257(200009)15:5<819::aid-mds1009>3.0.co;2-p. Mov Disord. 2000. PMID: 11009185

7

alpha-Synuclein gene haplotypes are associated with Parkinson's disease.

Farrer M, Maraganore DM, Lockhart P, Singleton A, Lesnick TG, de Andrade M, West A, de Silva R, Hardy J, Hernandez D. Farrer M, et al. Among authors: maraganore dm. Hum Mol Genet. 2001 Aug 15;10(17):1847-51. doi: 10.1093/hmg/10.17.1847. Hum Mol Genet. 2001. PMID: 11532993

8

LRRK2 mutations in Parkinson disease.

Farrer M, Stone J, Mata IF, Lincoln S, Kachergus J, Hulihan M, Strain KJ, Maraganore DM. Farrer M, et al. Among authors: maraganore dm. Neurology. 2005 Sep 13;65(5):738-40. doi: 10.1212/01.wnl.0000169023.51764.b0. Neurology. 2005. PMID: 16157908

9

Case-control study of estrogen receptor gene polymorphisms in Parkinson's disease.

Maraganore DM, Farrer MJ, McDonnell SK, Elbaz A, Schaid DJ, Hardy JA, Rocca WA. Maraganore DM, et al. Mov Disord. 2002 May;17(3):509-12. doi: 10.1002/mds.1253. Mov Disord. 2002. PMID: 12112198

10

Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease.

Goudreau JL, Maraganore DM, Farrer MJ, Lesnick TG, Singleton AB, Bower JH, Hardy JA, Rocca WA. Goudreau JL, et al. Among authors: maraganore dm. Mov Disord. 2002 Nov;17(6):1305-11. doi: 10.1002/mds.10268. Mov Disord. 2002. PMID: 12465073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters